Nektar Therapeutics - Company Profile
Powered by
All the data and insights you need on Nektar Therapeutics in one report.
$295
- Save hours of research time and resources with
our up-to-date Nektar Therapeutics Strategy Report
- Understand Nektar Therapeutics position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Nektar Therapeutics’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
21 Sep 2021 | Nektar Therapeutics Enters into Clinical Collaboration with Merck and Pfizer | Partnership | - |
Pfizer Inc Merck KGaA Nektar Therapeutics |
25 Feb 2021 | Biolojic Design Enters into Research Agreement with Nektar Therapeutics | Partnership | - |
Biolojic Design Ltd
Nektar Therapeutics |
17 Feb 2021 | Nektar Therapeutics Enters into Agreement with Merck | Partnership | - |
Nektar Therapeutics Merck & Co Inc |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer